Lanadelumab-Flyo 64538-0644
Product NDC
64538-0644- Manufacturer
- Rentschler Biopharma Se
- Dosage Form
- Injection, Solution
- Product Type
- Bulk Ingredient
- Marketing Start
- August 24, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lanadelumab | 300 mg/2mL |
Packaging Options(1)
5 mL in 1 VIAL, GLASS (64538-644-00)